GLF
MRNA icon

Groupe la Francaise’s Moderna MRNA Stock Holding History

Groupe la Francaise’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Buy
5,053
+48
+1% +$2.48K ﹤0.01% 368
2026
Q1 		$241K Sell
5,005
-1,000
-17% -$46.7K ﹤0.01% 369
2025
Q4 		$177K Sell
6,005
-12,409
-67% -$337K ﹤0.01% 373
2025
Q3 		$424K Buy
18,414
+8,569
+87% +$239K 0.01% 367
2025
Q2 		$270K Sell
9,845
-160
-2% -$4.21K ﹤0.01% 356
2025
Q1 		$338K Sell
10,005
-17,105
-63% -$607K 0.01% 339
2024
Q4 		$1.07M Buy
+27,110
New +$1.3M 0.03% 206

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Groupe la Francaise's MRNA Position: Q2 2026 in Review

Groupe la Francaise increased its Moderna (MRNA) stake by 0.96% in Q2 2026, buying an estimated $2.48K and bringing the position to 5,053 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #368.

Groupe la Francaise first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.07M in Q4 2024. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Groupe la Francaise held 5,053 shares of Moderna worth $353K as of Q2 2026.
  • Groupe la Francaise bought 48 Moderna shares in Q2 2026, an estimated $2.48K.
  • Moderna made up ﹤0.01% of Groupe la Francaise's portfolio in Q2 2026, its #368 holding.
  • Groupe la Francaise first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • Groupe la Francaise's Moderna position peaked at $1.07M in Q4 2024.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.